Skip Fleshman, a Managing Partner at Asset Management Ventures (AMV). See sector focus and contact routes.
Skip Fleshman, a Managing Partner at Asset Management Ventures (AMV), invests in early-stage (seed through Series B) startups in digital health, therapeutics, mobile, and data analytics, deploying $1 million to $15 million per round. His notable portfolio includes Freenome, Evidation Health, Lark, Reify Health, Arterys, and WellDoc, with a focus on companies disrupting clinical healthcare through data-driven defensibility. AMV’s distinctive thesis targets transformative, datadriven health technology teams with deep technical knowledge and unique technology in markets ripe for disruption.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Palo Alto when building a target list.
Investors like Skip Fleshman · Full investor directory · Investor access · Company funding database